Class ITerminatedD-0978-2015
Drug recall · May 13, 2015
iNDiGO capsules recall
Why: Marketed Without An Approved NDA/ANDA: Product was found to contain undeclared phenolphthalein, making iNDiGO an unapproved drug.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
iNDiGO capsules, 220 mg, 60-count bottle, Developed by Signature, 1027 Highway 70 W, Suite 227, Garner, NC 27529, UPC 8 52175 00404 4.
- Lots / codes
Lot: 000034, Exp 04/10/17
- Quantity
- 175 bottles
- Company
- Detox Transforms, Garner, NC
- Distribution
- WV who distributed Nationwide.
- Initiated
- January 25, 2015 · Voluntary: Firm initiated
- Classified
- May 4, 2015
- Reported
- May 13, 2015
- Ended
- January 23, 2017
- How notified
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Class ITerminatedMay 13, 2015EDGE Amplified Weight Release capsulesDetox Transforms · D-0977-2015Class ITerminatedMay 13, 2015AMPD GOLD Bee Pollen capsulesDetox Transforms · D-0979-2015Class ITerminatedMay 13, 2015BtRiM Max capsulesDetox Transforms · D-0980-2015Class ITerminatedMay 13, 2015iNSANE Bee Pollen capsulesDetox Transforms · D-0981-2015
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.